Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism

World Journal of Surgery

Volumn 33, Issue 11, 2009, Pages 2292-2302

  Weaver, Storm ^a   Doherty, David B ^a   Jimenez, Camilo ^a   Perrier, Nancy D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM SENSING RECEPTOR; COLECALCIFEROL; ERGOCALCIFEROL; ESTROGEN; FUROSEMIDE; GLUCOCORTICOID; LITHIUM; PARATHYROID HORMONE; PROGESTERONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

DIAGNOSTIC VALUE; EVIDENCE BASED MEDICINE; HUMAN; HYPERCALCEMIA; MEDICAL RESEARCH; PEER REVIEW; PRIMARY HYPERPARATHYROIDISM; REVIEW; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

HUMANS; HYPERPARATHYROIDISM, PRIMARY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70350031389     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-9966-9     Document Type: Review

References (57)

1. HA Bischoff-Ferrari 2008 Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes Adv Exp Med Biol 624 55 71 18348447 10.1007/978-0-387-77574-6-5
2. D Feldman 1999 Vitamin D, parathyroid hormone, and calcium: a complex regulatory network Am J Med 107 637 639 10625035 10.1016/S0002-9343(99)00283-1 1:CAS:528:DC%2BD3cXivF2hug%3D%3D
3. MF Holick 2007 Vitamin D deficiency N Engl J Med 357 266 281 17634462 10.1056/NEJMra070553 1:CAS:528:DC%2BD2sXotVejsbc%3D (Pubitemid 47080391)
4. MC Chapuy P Preziosi M Maamer, et al. 1997 Prevalence of vitamin D insufficiency in an adult normal population Osteoporos Int 7 439 443 9425501 10.1007/s001980050030 1:STN:280:DyaK1c%2Fos1Kgug%3D%3D (Pubitemid 27443069)
5. M Davies SE Heys PL Selby, et al. 1997 Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease J Clin Endocrinol Metab 82 209 212 8989260 10.1210/jc.82.1.209 1:CAS:528: DyaK2sXkt1emsg%3D%3D (Pubitemid 27021298)
6. MR Clements M Davies ME Hayes, et al. 1992 The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency Clin Endocrinol (Oxf) 37 17 27 10.1111/j.1365-2265.1992.tb02278.x 1:CAS:528:DyaK38XlslSjsrw%3D
7. SJ Silverberg E Shane DW Dempster, et al. 1999 The effects of vitamin D insufficiency in patients with primary hyperparathyroidism Am J Med 107 561 567 10625024 10.1016/S0002-9343(99)00294-6 1:CAS:528:DC%2BD3cXivF2htw%3D%3D
8. A Grey J Lucas A Horne, et al. 2005 Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency J Clin Endocrinol Metab 90 2122 2126 15644400 10.1210/jc.2004-1772 1:CAS:528: DC%2BD2MXjsFWjtLc%3D (Pubitemid 40586249)
9. DS Rao G Agarwal GB Talpos, et al. 2002 Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective J Bone Miner Res 17 Suppl 2 N75 80 12412781 1:CAS:528:DC%2BD38XoslemsLg%3D
10. DS Rao M Honasoge GW Divine, et al. 2000 Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications J Clin Endocrinol Metab 85 1054 1058 10720039 10.1210/jc.85.3.1054 1:CAS:528: DC%2BD3cXisFOru74%3D (Pubitemid 32269349)
11. E Nordenstrom J Westerdahl B Lindergard, et al. 2002 Multifactorial risk profile for bone fractures in primary hyperparathyroidism World J Surg 26 1463 1467 12297914 10.1007/s00268-002-6433-2 (Pubitemid 36920206)
12. PC Buchwald G Westin G Akerstrom 2005 Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review) Int J Mol Med 15 701 706 15754035 1:CAS:528:DC%2BD2MXjtFanurY%3D
13. AW Norman 1998 Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system Am J Clin Nutr 67 1108 1110 9625080 1:STN:280:DyaK1c3os1Ontg%3D%3D
14. JA MacLaughlin RR Anderson MF Holick 1982 Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin Science 216 1001 1003 6281884 10.1126/science.6281884 1:CAS:528: DyaL38XktVaqt7k%3D
15. TC Chen F Chimeh Z Lu, et al. 2007 Factors that influence the cutaneous synthesis and dietary sources of vitamin D Arch Biochem Biophys 460 213 217 17254541 10.1016/j.abb.2006.12.017 1:CAS:528:DC%2BD2sXksV2lt7Y%3D (Pubitemid 46613793)
16. MF Holick 2004 Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis Am J Clin Nutr 79 362 371 14985208 1:CAS:528:DC%2BD2cXhslOht74%3D
17. MT Hannan HJ Litman AB Araujo, et al. 2008 Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men J Clin Endocrinol Metab 93 40 46 17986641 10.1210/jc.2007-1217 1:CAS:528: DC%2BD1cXnsVOqtg%3D%3D
18. B Dawson-Hughes 2008 Serum 25-hydroxyvitamin D and functional outcomes in the elderly Am J Clin Nutr 88 537S 540S 18689397 1:CAS:528:DC%2BD1cXhtVSrsL3E
19. BW Hollis 2005 Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D J Nutr 135 317 322 15671234 1:CAS:528:DC%2BD2MXhsVKju74%3D
20. BW Hollis CL Wagner 2005 Normal serum vitamin D levels N Engl J Med 352 515 516 15689596 10.1056/NEJM200502033520521 1:CAS:528:DC%2BD2MXptlagsA%3D%3D (author reply 515-516)
21. JC Souberbielle E Lawson-Body B Hammadi, et al. 2003 The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects J Clin Endocrinol Metab 88 3501 3504 12915625 10.1210/jc.2003-030097 1:CAS:528:DC%2BD3sXmsFOksL0%3D (Pubitemid 37034484)
22. R Vieth 2006 What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92 26 32 16766239 10.1016/j.pbiomolbio.2006.02.003 1:CAS:528:DC%2BD28XlsFKrsb8%3D (Pubitemid 43842065)
23. P Szodoray B Nakken J Gaal, et al. 2008 The complex role of vitamin D in autoimmune diseases Scand J Immunol 68 261 269 18510590 10.1111/j.1365-3083. 2008.02127.x 1:CAS:528:DC%2BD1cXhtFajtrnN
24. F Baeke EV Etten C Gysemans, et al. 2008 Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities Mol Aspects Med 29 376 387 18621414 10.1016/j.mam.2008.05.004 1:CAS:528: DC%2BD1cXhtlyiur3K
25. ML Melamed ED Michos W Post, et al. 2008 25-hydroxyvitamin D levels and the risk of mortality in the general population Arch Intern Med 168 1629 1637 18695076 10.1001/archinte.168.15.1629
26. S Mocellin D Nitti 2008 Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis Cancer 113 2398 2407 18816636 10.1002/cncr.23867
27. RM Lally 2008 Vitamin D and cancer: more questions than answers remain ONS Connect 23 23 18807712
28. P Doro WB Grant R Benko, et al. 2008 Vitamin D and the seasonality of type 2 diabetes Med Hypotheses 71 317 318 18424013 10.1016/j.mehy.2008.03.005 1:CAS:528:DC%2BD1cXnvVyjtbo%3D
29. PN Sambrook JS Chen LM March, et al. 2004 Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population J Clin Endocrinol Metab 89 1572 1576 15070914 10.1210/jc.2003-031782 1:CAS:528:DC%2BD2cXjt1els7Y%3D (Pubitemid 38507904)
30. R Vieth TA Bayley PG Walfish, et al. 1991 Relevance of vitamin D metabolite concentrations in supporting the diagnosis of primary hyperparathyroidism Surgery 110 1043 1047 1745973 1:STN:280: DyaK38%2FotV2qsg%3D%3D
31. NA Younes Y Shafagoj F Khatib, et al. 2005 Laboratory screening for hyperparathyroidism Clin Chim Acta 353 1 12 15698586 10.1016/j.cccn.2004.10.003 1:CAS:528:DC%2BD2MXhtV2nurs%3D (Pubitemid 40215428)
32. DA Doherty KM Sanders MA Kotowicz, et al. 2001 Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women Osteoporos Int 12 16 23 11305078 10.1007/s001980170152 1:STN:280:DC%2BD3M3ivFKhtg%3D%3D (Pubitemid 32233654)
33. LJ Melton III 2002 The epidemiology of primary hyperparathyroidism in North America J Bone Miner Res 17 Suppl 2 N12 N17 12412772
34. E Lundgren EG Hagstrom J Lundin, et al. 2002 Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago World J Surg 26 931 936 12045863 10.1007/s00268-002-6621-0 (Pubitemid 36920289)
35. E Lundgren J Rastad E Thurfjell, et al. 1997 Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women Surgery 121 287 294 9092129 10.1016/S0039-6060(97) 90357-3 1:STN:280:DyaK2s3ks1Chtg%3D%3D (Pubitemid 27114448)
36. JP Bilezikian SJ Silverberg 2000 Clinical spectrum of primary hyperparathyroidism Rev Endocr Metab Disord 1 237 245 11706737 10.1023/A:1026508829397 1:STN:280:DC%2BD3Mnltl2lsA%3D%3D
37. R Jorde KH Bonaa J Sundsfjord 2000 Primary hyperparathyroidism detected in a health screening. The Tromso Study J Clin Epidemiol 53 1164 1169 11106891 10.1016/S0895-4356(00)00239-0 1:STN:280:DC%2BD3M%2FltV2htg%3D%3D
38. R Marcus P Madvig G Young 1984 Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans J Clin Endocrinol Metab 58 223 230 6319444 10.1210/jcem-58-2-223 1:CAS:528:DyaL2cXpslWmtQ%3D%3D
39. EA Yetley 2008 Assessing the vitamin D status of the U.S. population Am J Clin Nutr 88 558S 564S 18689402 1:CAS:528:DC%2BD1cXhtVSrsLrP
40. PN Sambrook JS Chen LM March, et al. 2004 Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study J Clin Endocrinol Metab 89 5477 5481 15531500 10.1210/jc.2004-0307 1:CAS:528: DC%2BD2cXhtVSisb3P (Pubitemid 39518428)
41. M Garabedian MF Holick HF Deluca, et al. 1972 Control of 25-hydroxycholecalciferol metabolism by parathyroid glands Proc Natl Acad Sci U S A 69 1673 1676 4340153 10.1073/pnas.69.7.1673 1:CAS:528:DyaE38Xlt1antLo%3D
42. RA Kaplan MR Haussler LJ Deftos, et al. 1977 The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria J Clin Invest 59 756 760 192763 10.1172/JCI108696 1:CAS:528:DyaE2sXktVemt78%3D
43. CY Pak M Oata EC Lawrence, et al. 1974 The hypercalciurias, Causes, parathyroid functions, and diagnostic criteria J Clin Invest 54 387 400 4367891 10.1172/JCI107774 1:CAS:528:DyaE2cXls1Ohurg%3D
44. JC Souberbielle C Cormier C Kindermans, et al. 2001 Vitamin D status and redefining serum parathyroid hormone reference range in the elderly J Clin Endocrinol Metab 86 3086 3090 11443171 10.1210/jc.86.7.3086 1:CAS:528: DC%2BD3MXlt1Gjsbc%3D (Pubitemid 32673470)
45. JP Bilezikian JT Potts Jr H Fuleihan Gel, et al. 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century J Clin Endocrinol Metab 87 5353 5361 12466320 10.1210/jc.2002-021370 1:CAS:528:DC%2BD38XpslWnsbY%3D (Pubitemid 36034328)
46. NH Bell A Greene S Epstein, et al. 1985 Evidence for alteration of the vitamin D-endocrine system in blacks J Clin Invest 76 470 473 3839801 10.1172/JCI111995 1:CAS:528:DyaL2MXltlGqu74%3D (Pubitemid 15227507)
47. JM Quesada W Coopmans B Ruiz, et al. 1992 Influence of vitamin D on parathyroid function in the elderly J Clin Endocrinol Metab 75 494 501 1639950 10.1210/jc.75.2.494 1:CAS:528:DyaK38Xls1Cgtb4%3D
48. JC Souberbielle V Fayol C Sault, et al. 2005 Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays Clin Chem 51 395 400 15563480 10.1373/clinchem.2004.037606 1:CAS:528: DC%2BD2MXhtVGgsro%3D (Pubitemid 40175810)
49. N Ozbey Y Erbil E Ademoglu, et al. 2006 Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism World J Surg 30 321 326 16467981 10.1007/s00268-005-0239-y (Pubitemid 43261355)
50. BR Untch ME Barfield M Dar, et al. 2007 Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism Surgery 142 1022 1026 18063090 10.1016/j.surg.2007.09.026 (Pubitemid 350184115)
51. TS Wang ST Ostrower KS Heller 2005 Persistently elevated parathyroid hormone levels after parathyroid surgery Surgery 138 1130 1136 16360400 10.1016/j.surg.2005.08.026 (Pubitemid 41797354)
52. TD Beyer CC Solorzano RA Prinz, et al. 2007 Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism Surgery 141 777 783 17560254 10.1016/j.surg.2007.01.025 (Pubitemid 46856568)
53. ZA Stewart A Blackford H Somervell, et al. 2005 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy Surgery 138 1018 1026 16360386 10.1016/j.surg.2005.09.018 (Pubitemid 41797340)
54. B Moosgaard P Vestergaard L Heickendorff, et al. 2006 Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study Eur J Endocrinol 155 237 244 16868136 10.1530/eje.1.02197 1:CAS:528:DC%2BD28XovFGht7Y%3D (Pubitemid 44269440)
55. H Raef S Ingemansson S Sobhi, et al. 2004 The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region J Endocrinol Invest 27 807 812 15648543 1:CAS:528:DC%2BD2MXhtlyit74%3D
56. PV Pradeep A Mishra G Agarwal, et al. 2008 Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency World J Surg 32 829 835 18204946 10.1007/s00268-007-9384-9 1:STN:280:DC%2BD1c3lslynsQ%3D%3D
57. PR von Hurst W Stonehouse C Matthys, et al. 2008 Study protocol-metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention BMC Public Health 8 267 10.1186/1471-2458-8-267